Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- The International Society of Peritoneal Dialysis Celebrates 40 Years Posted 10-15-2024
- Michael Aragon, MD Article in DocWireNews on Switching from PD to Home HD Posted 10-15-2024
- PD Excellence Academy Offers Three New Courses and Up to 11 CE Credits Posted 09-12-2024
- New Fresenius VersiĀ®HD Now has GuideMe Software Posted 09-12-2024